Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patients with Moderate to Severe Acute COVID-19: A Case Matched Control Study

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-136180

Published: 2020

Journal Articles

Impact of Amotosalen/UVA Pathogen Inactivated Platelet Components on Outcomes after Allogeneic Hematopoetic Stem Cell Transplantation: A Single Center Analysis

Andreas S. Buser, MD, Laura Infanti, MD, Andreas Holbro, MD, Joerg Halter, MD, Sabine Gerull, MD, Dominik Heim, MD, Michael Medinger, MD, Dimitrios A. Tsakiris, MD, Johannes Irsch, PhD, Jin-Sying Lin, PhD, Richard J. Benjamin, MD, Laurence Corash, MD, Jakob R. Passweg, MD

Blood (2019) 134 (Supplement_1): 1167.

https://doi.org/10.1182/blood-2019-122330

Published: 2019

Journal Articles

Hemoglobin Utilization in Asplenic and Non-Splenectomized Transfusion Dependent Thalassemia Patients Supported with Pathogen Reduced Red Blood Cell Concentrates in a Phase 3 Study (SPARC)

Yesim Aydinok, Antonio Piga, Raffaella Origa, MD, Nina Mufti, PhD, Anna Erikson, PhD, Anne North, PhD, Katie Waldhaus, Christine Ernst, MD, Jin-Sying Lin, PhD, Norman Huang, PhD, Richard J. Benjamin, MD, Laurence Corash, MD

Blood (2018) 132 (Supplement 1): 3812.

https://doi.org/10.1182/blood-2018-99-112685

Published: 2018

Journal Articles

A Sequential Cohort Study of Pathogen Reduced Platelet Component Transfusion without Use of Leukocyte Reduction for Hematopoietic Stem Cell Transplant (HSCT): Impact on Clinical Refractoriness

Laurence Corash, MD, Joycelyn Sim, MDMBBS, Wai-Chiu Tsoi, MD, Cheuk Kwong Lee, MD, Rock Y.Y. Leung, MD, Yingjie Liu, MD, Norman Huang, PhD, Clarence C.K. Lam, Hans Vermeij, Adonis Stassinopoulos, PhD BSc, MPhil, MA, Richard J. Benjamin, MD, Albert Kwok Wai Lie, MBBS,FRCP,FRCPath,FRCPA

Blood (2018) 132 (Supplement 1): 1257.

https://doi.org/10.1182/blood-2018-99-112305

Published: 2018

Journal Articles

Comparative Effectiveness and Safety Of Pathogen Inactivated (Amotosalen-UVA) and Conventional Plasma For Treatment Of Auto-Immmune Thrombotic Thrombocytopenic Purpura (TTP): A 15-Year Retrospective Review

Raoul Herbrecht, MD, Mario Ojeda-Uribe, MD, Daniel Kientz, MD, Alain Bohbot, MD, Olivier Hinschberger, MD, Cecile Fohrer, MD, Kun-Lun Liu, MD, Emilie Remy, Christine Ernst, MD, Laurence Corash, MD, Jean-Pierre Cazenave, MD, PhD

Blood (2013) 122 (21): 4820.

https://doi.org/10.1182/blood.V122.21.4820.4820

Published: 2013

Journal Articles

Assessing the Efficacy of RBC Component Transfusion Therapy in Patients with Thalassemia Major

William F. Reed, MD, Claire Sherman, Filomena Longo, Marianna Genisio, Laurence Corash, MD, Renzo Galanello, MD, Antonio Piga, MD

Blood (2012) 120 (21): 1185.

https://doi.org/10.1182/blood.V120.21.1185.1185

Published: 2012

Journal Articles

Safety Profile of Platelet Components Treated with Amotosalen-UVA Pathogen Inactivation Transfused in Routine Use: Multi-Year Active Hemovigilance.

Laurence Corash, MD

Blood (2012) 120 (21): 2278.

https://doi.org/10.1182/blood.V120.21.2278.2278

Published: 2012

Journal Articles

Prevention of Transfusion-Associated Graft Versus Host Disease (TA-GVHD) by Photochemical Treatment of Platelet Components: Clinical Experience in Routine Use.

Jean Claude Osselaer, MD, JD, Chantal Doyen, MD, Carlos Graux, MD, Christian Chatelain, MD, Anne Sonnet, MD, Michele Jacquet, MS, Jin Sying Lin, PhD, Laurence Corash, MD, Andre Bosly, MD, PhD

Blood (2007) 110 (11): 2885.

https://doi.org/10.1182/blood.V110.11.2885.2885

Published: 2007

Journal Articles

Release of Immune Modulation Factors from Platelet Concentrates during Storage after Photochemical Pathogen Inactivation.

Laurence Corash, MD, Fabrice Cognasse, PhD, Jean-Claude Osselaer, MD, JD, Natalie Messe, Olivier Garraud, MD, PhD

Blood (2006) 108 (11): 941.

https://doi.org/10.1182/blood.V108.11.941.941

Published: 2006

Journal Articles

Effects of Pathogen Inactivation Using Amotosalen-UVA on Coagulation Parameters in Apheresis and Whole Blood Derived Frozen Plasma in a Large Blood Bank Setting.

Markus M. Mueller, MD, Hans-Ulrich Pfeiffer, Margaret Rheinschmidt, PhD, Bernd Poetzsch, MD, PhD, Johannes Oldenburg, MD, PhD, Laurence Corash, MD, PhD, Erhard Seifried, MD, PhD, Reinhard Henschler, MD, PhD

Blood (2006) 108 (11): 942.

https://doi.org/10.1182/blood.V108.11.942.942

Published: 2006

Journal Articles

Cytokines in Platelet Components Associated with Acute Transfusion Reactions: The Role of sCD40L.

Laurence Corash, MD, Fabrice Cognasse, PhD, Jean-Claude Osselaer, MD, JD, Natalie Messe, Maryse Van Hooydonk, RN, Olivier Garraud, MD, PhD

Blood (2006) 108 (11): 952.

https://doi.org/10.1182/blood.V108.11.952.952

Published: 2006

Journal Articles

Routine Use of Platelet Components Prepared with Photochemical Treatment (INTERCEPT Platelets™): Impact on Clinical Outcomes and Resources.

Jean Claude Osselaer, MD, JD, Chantal Doyen, MD, Natalie Messe, Maryse Van Hooydonk, RN, Michele Jacquet, MS, Anne Sonnet, MD, Andre Bosly, MD, PhD, Jocelyne Flament, MD, Laurence Corash, MD

Blood (2005) 106 (11): 429.

https://doi.org/10.1182/blood.V106.11.429.429

Published: 2005

Journal Articles

Antibodies to S-303 Treated RBC Prepared with the Original Treatment Process (OSRBC) for Pathogen Inactivation Do Not React with RBC Prepared with a Modified S-303 Treatment Process (MSRBC).

Maureen G. Conlan, MD, George Garratty, PhD, FRCPath, Grace Castro, Anna Erickson, Mary Ann Schott, Pat Arndt, David Cook, PhD, Laurence Corash, MD, Adonis Stassinopoulos, PhD

Blood (2005) 106 (11): 430.

https://doi.org/10.1182/blood.V106.11.430.430

Published: 2005

Journal Articles

Leucocyte-Reduced Buffy Coat Platelet Concentrates (BCPC) Treated with INTERCEPT™ Stored up to 7 Days: Hemostatic Function in a Whole Blood Flow System.

Miguel Lozano, MD, PhD, Ana Galan, PhD, Roberto Mazzara, MD, PhD, Laurence Corash, MD, Gines Escolar, MD, PhD

Blood (2005) 106 (11): 956.

https://doi.org/10.1182/blood.V106.11.956.956

Published: 2005

Journal Articles

Assessment of the Economic Value of the Intercept Blood System for Platelets in Belgium.

Karen Moeremans, MD, Hans Warie, MD, Lieven Annemans, PhD, Toon Digneffe, MSc, Jacques Toté, MSc, Laurence Corash, MD

Blood (2004) 104 (11): 3156.

https://doi.org/10.1182/blood.V104.11.3156.3156

Published: 2004

Journal Articles

An Increase in the Immature Platelet Fraction Predicts Reconstitution of the Platelet Count and May Reduce Prophylactic Platelet Transfusions after Stem Cell Transplantation.

Samuel J. Machin, FRCP FRCPath, Dan Hart, Bsc MBChB MRCP, Stefan Kunka, FIBMS, Carol Briggs, BSc FIBMS, Laurence Corash, MD

Blood (2004) 104 (11): 3632.

https://doi.org/10.1182/blood.V104.11.3632.3632

Published: 2004

Journal Articles

Transfusion of S-303 Treated RBCs To Treat Acute Anemia during or Following Cardiac Surgery: Results of a Phase III Trial.

Richard J. Benjamin, MB CHB PhD, Jeffrey McCullough, MD, Paul D. Mintz, MD, Edward L. Snyder, MD, William D. Spotnitz, MD, David Wages, MD, PhD, Lindsey Wood, PhD, Jaime Houghton, Jin-Sying Lin, PhD, Laurence Corash, MD, Maureen G. Conlan, MD

Blood (2004) 104 (11): 381.

https://doi.org/10.1182/blood.V104.11.381.381

Published: 2004

Journal Articles

Antibody Formation to S-303-Treated RBCS in the Setting of Chronic RBC Transfusion.

Maureen G. Conlan, MD, Adonis Stassinopoulos, PhD, George Garratty, PhD, David Wages, MD, PhD, Laurence Corash, MD, Lindsey Wood, PhD, Steven R. Sloan, MD, Richard J. Labotka, MD

Blood (2004) 104 (11): 382.

https://doi.org/10.1182/blood.V104.11.382.382

Published: 2004

Journal Articles

Routine Use of Platelet Components Prepared with Photochemical Treatment (INTERCEPT Platelets) : Impact on Clinical Outcomes and Costs.

Jean Claude Osselaer, MD, JD, Chantal Doyen, MD, Anne Sonet, MD, Maryse Van Hooydonk, RN, Edith Goossenaerts, RN, Christian Chatelain, MD, Andre Bosly, MD, PhD, Laurence Corash, MD

Blood (2004) 104 (11): 3629.

https://doi.org/10.1182/blood.V104.11.3629.3629

Published: 2004

NARROW

Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patients with Moderate to Severe Acute COVID-19: A Case Matched Control Study

Impact of Amotosalen/UVA Pathogen Inactivated Platelet Components on Outcomes after Allogeneic Hematopoetic Stem Cell Transplantation: A Single Center Analysis

Hemoglobin Utilization in Asplenic and Non-Splenectomized Transfusion Dependent Thalassemia Patients Supported with Pathogen Reduced Red Blood Cell Concentrates in a Phase 3 Study (SPARC)

A Sequential Cohort Study of Pathogen Reduced Platelet Component Transfusion without Use of Leukocyte Reduction for Hematopoietic Stem Cell Transplant (HSCT): Impact on Clinical Refractoriness

Comparative Effectiveness and Safety Of Pathogen Inactivated (Amotosalen-UVA) and Conventional Plasma For Treatment Of Auto-Immmune Thrombotic Thrombocytopenic Purpura (TTP): A 15-Year Retrospective Review

Assessing the Efficacy of RBC Component Transfusion Therapy in Patients with Thalassemia Major

Safety Profile of Platelet Components Treated with Amotosalen-UVA Pathogen Inactivation Transfused in Routine Use: Multi-Year Active Hemovigilance.

Prevention of Transfusion-Associated Graft Versus Host Disease (TA-GVHD) by Photochemical Treatment of Platelet Components: Clinical Experience in Routine Use.

Release of Immune Modulation Factors from Platelet Concentrates during Storage after Photochemical Pathogen Inactivation.

Effects of Pathogen Inactivation Using Amotosalen-UVA on Coagulation Parameters in Apheresis and Whole Blood Derived Frozen Plasma in a Large Blood Bank Setting.

Cytokines in Platelet Components Associated with Acute Transfusion Reactions: The Role of sCD40L.

Routine Use of Platelet Components Prepared with Photochemical Treatment (INTERCEPT Platelets™): Impact on Clinical Outcomes and Resources.

Antibodies to S-303 Treated RBC Prepared with the Original Treatment Process (OSRBC) for Pathogen Inactivation Do Not React with RBC Prepared with a Modified S-303 Treatment Process (MSRBC).

Leucocyte-Reduced Buffy Coat Platelet Concentrates (BCPC) Treated with INTERCEPT™ Stored up to 7 Days: Hemostatic Function in a Whole Blood Flow System.

Assessment of the Economic Value of the Intercept Blood System for Platelets in Belgium.

An Increase in the Immature Platelet Fraction Predicts Reconstitution of the Platelet Count and May Reduce Prophylactic Platelet Transfusions after Stem Cell Transplantation.

Transfusion of S-303 Treated RBCs To Treat Acute Anemia during or Following Cardiac Surgery: Results of a Phase III Trial.

Antibody Formation to S-303-Treated RBCS in the Setting of Chronic RBC Transfusion.

Routine Use of Platelet Components Prepared with Photochemical Treatment (INTERCEPT Platelets) : Impact on Clinical Outcomes and Costs.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only